These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 2037383)

  • 1. Passive immunization of hamsters against disease caused by Clostridium difficile by use of bovine immunoglobulin G concentrate.
    Lyerly DM; Bostwick EF; Binion SB; Wilkins TD
    Infect Immun; 1991 Jun; 59(6):2215-8. PubMed ID: 2037383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with Bacillus spores expressing toxin A peptide repeats protects against infection with Clostridium difficile strains producing toxins A and B.
    Permpoonpattana P; Hong HA; Phetcharaburanin J; Huang JM; Cook J; Fairweather NF; Cutting SM
    Infect Immun; 2011 Jun; 79(6):2295-302. PubMed ID: 21482682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of formalin-inactivated Clostridium difficile vaccines administered by parenteral and mucosal routes of immunization in hamsters.
    Torres JF; Lyerly DM; Hill JE; Monath TP
    Infect Immun; 1995 Dec; 63(12):4619-27. PubMed ID: 7591115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active and passive immunization to protect against antibiotic associated caecitis in hamsters.
    Fernie DS; Thomson RO; Batty I; Walker PD
    Dev Biol Stand; 1983; 53():325-32. PubMed ID: 6873474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperimmune bovine colostrum for treatment of GI infections: a review and update on Clostridium difficile.
    Steele J; Sponseller J; Schmidt D; Cohen O; Tzipori S
    Hum Vaccin Immunother; 2013 Jul; 9(7):1565-8. PubMed ID: 23435084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nontoxigenic Clostridium difficile protects hamsters against challenge with historic and epidemic strains of toxigenic BI/NAP1/027 C. difficile.
    Nagaro KJ; Phillips ST; Cheknis AK; Sambol SP; Zukowski WE; Johnson S; Gerding DN
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5266-70. PubMed ID: 23939887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against experimental pseudomembranous colitis in gnotobiotic mice by use of monoclonal antibodies against Clostridium difficile toxin A.
    Corthier G; Muller MC; Wilkins TD; Lyerly D; L'Haridon R
    Infect Immun; 1991 Mar; 59(3):1192-5. PubMed ID: 1900059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum antitoxin antibodies mediate systemic and mucosal protection from Clostridium difficile disease in hamsters.
    Giannasca PJ; Zhang ZX; Lei WD; Boden JA; Giel MA; Monath TP; Thomas WD
    Infect Immun; 1999 Feb; 67(2):527-38. PubMed ID: 9916055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and evaluation of an ovine antibody-based platform for treatment of Clostridium difficile infection.
    Roberts A; McGlashan J; Al-Abdulla I; Ling R; Denton H; Green S; Coxon R; Landon J; Shone C
    Infect Immun; 2012 Feb; 80(2):875-82. PubMed ID: 22144483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a recombinant toxin fragment vaccine for Clostridium difficile infection.
    Karczewski J; Zorman J; Wang S; Miezeiewski M; Xie J; Soring K; Petrescu I; Rogers I; Thiriot DS; Cook JC; Chamberlin M; Xoconostle RF; Nahas DD; Joyce JG; Bodmer JL; Heinrichs JH; Secore S
    Vaccine; 2014 May; 32(24):2812-8. PubMed ID: 24662701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal Immunization with the C-Terminal Domain of Bcla3 Induced Specific IgG Production and Attenuated Disease Symptoms in Mice Infected with
    Maia AR; Reyes-Ramírez R; Pizarro-Guajardo M; Saggese A; Ricca E; Baccigalupi L; Paredes-Sabja D
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32933117
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-Clostridium difficile bovine immunoglobulin concentrate inhibits cytotoxicity and enterotoxicity of C. difficile toxins.
    Kelly CP; Pothoulakis C; Vavva F; Castagliuolo I; Bostwick EF; O'Keane JC; Keates S; LaMont JT
    Antimicrob Agents Chemother; 1996 Feb; 40(2):373-9. PubMed ID: 8834883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization using GroEL decreases Clostridium difficile intestinal colonization.
    Péchiné S; Hennequin C; Boursier C; Hoys S; Collignon A
    PLoS One; 2013; 8(11):e81112. PubMed ID: 24303034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic antibody responses induced by a two-component Clostridium difficile toxoid vaccine protect against C. difficile-associated disease in hamsters.
    Anosova NG; Brown AM; Li L; Liu N; Cole LE; Zhang J; Mehta H; Kleanthous H
    J Med Microbiol; 2013 Sep; 62(Pt 9):1394-1404. PubMed ID: 23518659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Passive immunisation of hamsters against Clostridium difficile infection using antibodies to surface layer proteins.
    O'Brien JB; McCabe MS; Athié-Morales V; McDonald GS; Ní Eidhin DB; Kelleher DP
    FEMS Microbiol Lett; 2005 May; 246(2):199-205. PubMed ID: 15899406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bovine immunoglobulin concentrate-clostridium difficile retains C difficile toxin neutralising activity after passage through the human stomach and small intestine.
    Warny M; Fatimi A; Bostwick EF; Laine DC; Lebel F; LaMont JT; Pothoulakis C; Kelly CP
    Gut; 1999 Feb; 44(2):212-7. PubMed ID: 9895380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of anti-Clostridium difficile bovine immunoglobulin concentrate in the human gastrointestinal tract.
    Kelly CP; Chetham S; Keates S; Bostwick EF; Roush AM; Castagliuolo I; LaMont JT; Pothoulakis C
    Antimicrob Agents Chemother; 1997 Feb; 41(2):236-41. PubMed ID: 9021173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization of adult hamsters against Clostridium difficile-associated ileocecitis and transfer of protection to infant hamsters.
    Kim PH; Iaconis JP; Rolfe RD
    Infect Immun; 1987 Dec; 55(12):2984-92. PubMed ID: 3679541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human monoclonal antibodies directed against toxins A and B prevent Clostridium difficile-induced mortality in hamsters.
    Babcock GJ; Broering TJ; Hernandez HJ; Mandell RB; Donahue K; Boatright N; Stack AM; Lowy I; Graziano R; Molrine D; Ambrosino DM; Thomas WD
    Infect Immun; 2006 Nov; 74(11):6339-47. PubMed ID: 16966409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of vaccine for Clostridium difficile infection using membrane fraction of nontoxigenic Clostridium difficile.
    Senoh M; Iwaki M; Yamamoto A; Kato H; Fukuda T; Shibayama K
    Microb Pathog; 2018 Oct; 123():42-46. PubMed ID: 29959036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.